Teresa Greco

Jazz Pharmaceuticals (United States) — United States

Medicine · Health Sciences

36h-index5.2kcitations97works0.82yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Pain Management and Opioid Use(20), Cardiac, Anesthesia and Surgical Outcomes(16), Pharmacological Effects and Toxicity Studies(10), Anesthesia and Sedative Agents(9), Mechanical Circulatory Support Devices(9)

Publications97 total

Long‐term efficacy and safety of cannabidiol in patients with treatment‐resistant focal epilepsies treated in the Expanded Access Program
Epilepsia·2025· 3 citedOpen Access
Antenatal care services and pregnancy outcomes during the COVID-19 pandemic in Milan, Lombardy, Italy.
PubMed·2025
[A data-driven approach to optimizing the management of chronic patients within the framework of DM77].
PubMed·2025
Tuberous Sclerosis Complex (TSC)–Associated Neuropsychiatric Disorder (TAND) Outcomes Following Add-on Cannabidiol (CBD) Treatment: 3-Month Analysis of Open-Label Phase 3b/4 Trial EpiCom (P8-9.005)
Neurology·2025
Access to health services by women subjected to violence: findings from administrative healthcare data from the metropolitan area of northern Italy
BMC Women s Health·2025· 2 citedOpen Access
Access to health services by children exposed to violence: a cross-sectional study on findings from Health Care Utilization data of the Health Protection Agency (ATS) of the Metropolitan City of Milan
SSRN Electronic Journal·2025Open Access
Access to health services by women subjected to violence: findings from administrative healthcare data from the metropolitan area of northern Italy
2024Open Access
Real-world Safety and Effectiveness of Cannabidiol (CBD) in Adults with Treatment-resistant Epilepsies (TREs): Long-term Results from the United States Expanded Access Program (EAP) (P8-1.002)
Neurology·2024
Long-term Effectiveness of Cannabidiol (CBD) Against Focal Seizures in Tuberous Sclerosis Complex (TSC): Results from the GWPCARE6 Open-label Extension (OLE) Trial (P8-1.001)
Neurology·2024· 1 cited
Long-term Effectiveness of Cannabidiol (CBD) Against Focal-onset Seizures in Treatment-resistant Epilepsies (TRE): Experience from the Expanded Access Program (EAP) (S29.005)
Neurology·2024· 1 cited
Application of the Bayesian network theory in clinical trial data: Severity shift in spasticity numeric rating scale in patients with multiple sclerosis
Multiple Sclerosis and Related Disorders·2024· 2 citedOpen Access
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effects
Australian & New Zealand Journal of Psychiatry·2023· 10 citedOpen Access
Does response to vagus nerve stimulation for drug‐resistant epilepsy differ in patients with and without Lennox–Gastaut syndrome?
Brain and Behavior·2023· 10 citedOpen Access
EE292 Health Care Resource Utilization and Medical Costs before and after Initiation of Epidiolex in Commercially Insured Patients in the US
Value in Health·2023· 1 cited
Author response for "Does response to vagus nerve stimulation for drug‐resistant epilepsy differ in patients with and without Lennox–Gastaut syndrome?"
2023
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life
Psychological Medicine·2023· 11 citedOpen Access
A <i>post hoc</i> evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols
Therapeutic Advances in Neurological Disorders·2023Open Access
Pain management and outcomes in cancer patients: comparison between oncological and palliative sets of care
Epidemiology Biostatistics and Public Health·2022· 1 citedOpen Access
Improving quality of care for cancer pain: an Italian five-year project
Epidemiology Biostatistics and Public Health·2022Open Access
A prospective, multi-center randomized, controlled, blinded trial of vagus nerve stimulation for difficult to treat depression: A novel design for a novel treatment
Brain stimulation·2021· 2 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Alberto Zangrillo(27), Giovanni Landoni(24), Giuseppe Biondi‐Zoccai(15), Laura Pasin(10), Federico Pappalardo(8), Giovanni Apolone(8), Luca Cabrini(8), Massimiliano Greco(7), Silvia Deandrea(6), Oscar Corli(6), Mauro Montanari(6), Marina Pieri(5), Roberto Ratiglia(5), Oscar Corli(5), Gabriele Finco(5), Michele De Bonis(4), Caetano Nigro Neto(4), Andrea Morelli(3), Daniela Febres(3), Augusto Caraceni(3)